Series A warrants are typically issued alongside Series A preferred stock or Series A financing rounds, and they represent some of the earliest and most deeply embedded dilution in a company's capital structure. According to DilutionWatch data covering 7,300+ stocks, Series A warrants often have favorable terms for the original investors that create significant dilution potential for later shareholders, particularly those who bought shares on the public market.
Series A warrants typically have lower exercise prices than later-round warrants because they were priced during earlier stages of the company's development when valuations were lower. If the company was valued at $2 per share during its Series A round, Series A warrants might have exercise prices of $2-3, making them deeply in-the-money if the stock later trades at $10+. This creates near-certain dilution from these early warrants.
The terms of Series A warrants often include anti-dilution protections that adjust the exercise price downward if the company issues shares at lower prices in subsequent rounds. This means that a company experiencing financial difficulty and issuing shares at depressed prices may simultaneously trigger anti-dilution adjustments that make Series A warrants even more dilutive. This compounding effect can amplify the impact of down-round financing on common shareholders.
For public company investors, Series A warrants represent legacy dilution from the company's private history. These warrants may have been issued years before the IPO and may not be immediately obvious in current financial statements. DilutionWatch traces warrant history back to the company's earliest SEC filings to identify and track all outstanding warrant series, including those from pre-IPO financing rounds.
Evaluating Series A warrant risk requires understanding the total quantity outstanding, the current exercise price (after any anti-dilution adjustments), the expiration date, and any registration rights that allow the warrant holders to sell shares immediately upon exercise. DilutionWatch incorporates all of these factors into the DilutionScore™, providing a comprehensive assessment that accounts for legacy warrant dilution from all financing rounds.
Series A warrants are warrants issued alongside Series A financing rounds, typically during a company's early stages. They usually have lower exercise prices and longer terms than warrants from later rounds, creating significant dilution potential for shareholders who invest later.
They have low exercise prices (often deeply in-the-money by the time the stock is publicly traded), anti-dilution protections that can lower the exercise price further, and may represent large quantities relative to the public float.
Look in the equity footnotes of 10-K annual reports, which typically list all outstanding warrant series with their terms. The company's S-1 registration statement (from the IPO) usually provides the most comprehensive historical warrant disclosure. DilutionWatch tracks all warrant series from all financing rounds.
DilutionWatch monitors 7,300+ stocks for dilution risk in real time. Get the DilutionScore™ for any ticker instantly.
Search DilutionWatch →